Company Summary: Korro Bio is a privately held biotechnology company dedicated to the discovery and development of a new class of precision genetic medicines using our proprietary RNA editing platform, OPERA. Our portfolio of innovative RNA therapies has the potential to advance genetic medicine beyond rare genetic diseases and into larger patient populations with common diseases. We have locations in Cambridge and Woburn, Massachusetts.